Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ASX/UBI stock hub

ASX/UBI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/UBIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.2M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/UBI

In the news

Latest news · ASX/UBI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-111

P25 -118.7P50 -49.4P75 -1.2

ROIC-195.6

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/UBI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

AUD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AU
Employees	76
Employees Change	-4%
Employees Change Percent	-5
Enterprise value	AUD 5M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Medical Devices
Isin	AU000000UBI2
Last refreshed	2026-05-10
Market cap	AUD 4.2M
Price	AUD 0.01
Price currency	AUD
Rev Per Employee	78,303.75x
Sector	Healthcare
Sic	2835
Symbol	asx/UBI
Website	https://www.universalbiosensors.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-418.3%
EV Earnings	-0.29x
EV/FCF	-0.38x
EV/Sales	0.84x
FCF yield	-319.03%
P/B ratio	0.59x
P/S ratio	0.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	26.73%
Gross Profit	AUD 1.6M
Gross Profit Growth	-65.74%
Gross Profit Growth3 Y	-7.11%
Gross Profit Growth5 Y	11.16%
Net Income	AUD -17.5M
Net Income Growth Years	0%
Pretax Margin	-293.32%
Profit Margin	-293.32%
Profit Per Employee	AUD -229,678
ROA	-52.1
Roa5y	-26.03
ROCE	-186.7
ROE	-111
Roe5y	-51.43
ROIC	-195.6
Roic5y	-140.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.7%
Cagr15y	-26.68%
Cagr1y	-90.02%
Cagr3y	-62.87%
Cagr5y	-46.07%
EPS Growth Years	0
Revenue Growth	-16.52x
Revenue Growth Q	-25.64x
Revenue Growth Years	0x
Revenue Growth3 Y	2.85x
Revenue Growth5 Y	8.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.25
Assets	AUD 14.9M
Cash	AUD 2.2M
Current Assets	AUD 8M
Current Liabilities	AUD 4.2M
Debt	AUD 3M
Debt Equity	AUD 0.43
Debt FCF	AUD -0.23
Equity	AUD 7.1M
Interest Coverage	-2,012.2
Liabilities	AUD 7.9M
Long Term Assets	AUD 6.9M
Long Term Liabilities	AUD 3.6M
Net Cash	AUD -847,863
Net Cash By Market Cap	AUD -20.32
Net Debt Equity	AUD 0.12
Tangible Book Value	AUD 7.1M
Tangible Book Value Per Share	AUD 0.02
WACC	3.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	1
Net Working Capital	AUD 2.4M
Quick ratio	0.69
Working Capital	AUD 3.8M
Working Capital Turnover	AUD 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.1%
1Y total return	-90%
200-day SMA	0.08
3Y total return	-94.89%
50-day SMA	0.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.44%
All Time High	2.2
All Time High Change	-99.36%
All Time High Date	2009-11-11
All Time Low	0.01
All Time Low Change	16.67%
All Time Low Date	2025-08-18
ATR	0
Beta	0.15
Beta1y	0.11
Beta2y	0.14
Ch YTD	-86.67
High	0.01
High52	0.16
High52 Date	2024-10-07
High52ch	-91.25%
Low	0.01
Low52	0.01
Low52 Date	2025-08-18
Low52ch	16.67%
Ma50ch	-50.53%
Price vs 200-day SMA	-82.65%
RSI	30.96
RSI Monthly	24.95
RSI Weekly	15.82
Sharpe ratio	-1.77x
Sortino ratio	-2.35
Total Return	-31.15%
Tr YTD	-86.67
Tr15y	-99.05%
Tr1m	-41.67%
Tr1w	-41.67%
Tr3m	-71.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -20M
Operating margin	-336

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-795,407
Shares Insiders	1.91%
Shares Institutions	25.84%
Shares Out	298,067,435
Shares Qo Q	0%
Shares Yo Y	31.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -13.3M
Average Volume	615,065.75x
Bv Per Share	0.02
CAPEX	AUD -340,158
Ch10y	-96.32
Ch15y	-99.1
Ch1m	-41.67
Ch1w	-41.67
Ch1y	-90
Ch3m	-71.43
Ch3y	-95.17
Ch5y	-95.69
Ch6m	-81.58
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	652,972
Dollar Volume	1,848.6
Earnings Date	2026-05-11
EBIT	AUD -20M
EBITDA	AUD -19.3M
EPS	AUD -0.06
F Score	2
FCF	AUD -13.3M
FCF EV Yield	-265.16x
FCF Per Share	AUD -0.04
Financing CF	-1,191,357
Fiscal Year End	December
Founded	2,001
Investing CF	-340,158
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-06-30
Ma150	0.06
Ma150ch	-77.78%
Ma20	0.02
Ma20ch	-35.78%
Net CF	-14,477,494
Next Earnings Date	2026-05-11
Open	0.01
Position In Range	100
Ppne	6,491,021
Price Date	2026-02-12
Ptbv Ratio	0.59
Relative Volume	0.21x
Revenue	5,951,085x
SBC By Revenue	0.55x
Share Based Comp	33,000
Tr6m	-81.58%
Volume	132,045
Z Score	-12.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/UBI pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/UBI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/UBI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.8%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+31.1%

Negative means the company is buying back shares.

Technical

ASX/UBI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.0

Neutral momentum band

Price vs 200-day MA

-82.7%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

-1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/UBI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/UBI stock rating?

asx/UBI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/UBI analysis?

The full report lives at /stocks/asx/UBI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/UBI?

The latest report frames asx/UBI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/UBI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.